{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:07:18Z","timestamp":1793747238352,"version":"4.6.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer remains a leading cause of cancer-related mortality among women in Sub-Saharan Africa (SSA), where access to laboratory-based screening is limited. Point-of-care (POC) HPV testing enables rapid, near-patient diagnostics that support same-day screen- and treat strategies; however, the evidence base across SSA remains fragmented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a scoping review following the Arksey and O\u2019 Malley and the Joanna Briggs Institute (JBI) framework. Ten electronic databases and grey literature sources (2000\u20132025) were searched for studies evaluating POC HPV tests in SSA. Data on platform characteristics, diagnostic performance, feasibility, acceptability, barriers, facilitators, and sustainability were extracted and synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-one unique studies from 15 SSA countries evaluated seven POC HPV platforms (Xpert HPV, careHPV\u2122, AmpFire HPV, LAMP (DARQ), ScreenFire, 8-HPV OncoE6\/E7, OncoE6\u2122). Xpert HPV consistently demonstrated high sensitivity for CIN2\u2009+\u2009lesions (71\u201397%) and CIN3\u2009+\u2009lesions (68\u201399%) based on histology-confirmed lesions, with moderate specificity (59\u201371%) when using biopsy-confirmed histopathology as the reference standard. OncoE6\u2122 exhibited high specificity (98\u201399%) but lower sensitivity (31\u201357%). CareHPV performance varied widely (sensitivity 54\u201397%, specificity 54\u201394%) and, as with other POC HPV platforms, was influenced by HIV status, sample type, and clinical setting. Acceptability among women was high, especially for self-sampling and rapid results; provider acceptability was supported by minimal training requirement. Evidences from implementation studies suggest that POC HPV testing is operationally feasible in SSA, though key barriers include test costs, supply chain interruptions, and challenges in patient follow-up. Facilitators for feasibility and scale-up include integration with HIV\/TB services, community-based outreach, and streamlined workflows. However, data on large-scale implementation, cost-effectiveness, and sustainability remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>POC HPV testing in SSA demonstrates adequate diagnostic performance and high acceptability, and feasibility under programmatic conditions. In settings with healthcare infrastructure similar to that of Ethiopia, successful scale-up of POC HPV testing will require integration with the existing health services, strengthened quality assurance, providers training, and robust patient follow-up mechanisms. Future research should focus on implementation trials, cost-effectiveness, effective triage strategies, and long-term sustainability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-26382-9","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:33:48Z","timestamp":1769402028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Point-of-care HPV testing for cervical cancer screening in Sub-Saharan Africa: platform diversity, diagnostic performance, implementation feasibility, and determinants\u2014a scoping review with contextual considerations for Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Melkamu","family":"Siferih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet","family":"Gedif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anteneh","family":"Lamesgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alehegn Aderaw","family":"Alamneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebaw Abeje","family":"Muluneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilkal Dagnaw","family":"Melesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Tilaye","family":"Mihiret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menberu","family":"Gete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmamaw","family":"Getnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haile","family":"Amha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysheshim Asnake","family":"Abneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsede Alle","family":"Ewunetie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadele Derbew","family":"Kassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"26382_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41416-020-0831-9","volume":"123","author":"E Jedy-Agba","year":"2020","unstructured":"Jedy-Agba E, Joko WY, Liu B, Buziba N, Borok M, Korir A, et al. Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer. 2020;123:148\u201354.","journal-title":"Br J Cancer"},{"key":"26382_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgc.2024.100008","volume":"35","author":"C Anakwenze","year":"2025","unstructured":"Anakwenze C, Kalra A, Lumley C, Chinniah G, Munsell M, Rajan T, et al. Cervical cancer stage distribution and survival outcomes in africa: a systematic review and meta-analysis. Int J Gynecol Cancer: Official J Int Gynecol Cancer Soc. 2025;35:1.","journal-title":"Int J Gynecol Cancer: Official J Int Gynecol Cancer Soc"},{"key":"26382_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ijgc-2022-003957","volume":"33","author":"T Dzinamarira","year":"2022","unstructured":"Dzinamarira T, Moyo E, Dzobo M, Mbunge E, Murewanhema G. Cervical cancer in sub-Saharan africa: an urgent call for improving accessibility and use of preventive services. Int J Gynecol Cancer. 2022;33:592\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"26382_CR4","unstructured":"Organization WH. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020."},{"key":"26382_CR5","unstructured":"Organization WH. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021."},{"issue":"1","key":"26382_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","volume":"22","author":"Z Petersen","year":"2022","unstructured":"Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022;22(1):486.","journal-title":"BMC Womens Health"},{"key":"26382_CR7","doi-asserted-by":"publisher","first-page":"670032","DOI":"10.3389\/fpubh.2021.670032","volume":"9","author":"MB Shin","year":"2021","unstructured":"Shin MB, Liu G, Mugo N, Garcia PJ, Rao DW, Broshkevitch CJ, et al. A framework for cervical cancer elimination in Low-and-Middle-Income countries: A scoping review and roadmap for interventions and research priorities. Front Public Health. 2021;9:670032.","journal-title":"Front Public Health"},{"key":"26382_CR8","doi-asserted-by":"publisher","first-page":"111707","DOI":"10.1016\/j.jclinepi.2025.111707","volume":"180","author":"BT Meteku","year":"2025","unstructured":"Meteku BT, De Silva K, Green SE, Turner T. Guideline developers in low- and middle-income countries want to develop and use living guidelines, but are currently limited by important barriers: findings from a qualitative study. J Clin Epidemiol. 2025;180:111707.","journal-title":"J Clin Epidemiol"},{"key":"26382_CR9","doi-asserted-by":"crossref","unstructured":"Koliopoulos G, Nyaga V, Santesso N, Bryant A, Martin-Hirsch P, Mustafa R et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8.","DOI":"10.1002\/14651858.CD008587.pub2"},{"key":"26382_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ygyno.2024.09.013","volume":"191","author":"S Lindquist","year":"2024","unstructured":"Lindquist S, Kj\u00e6r S, Frederiksen K, \u00d8rnskov D, Munk C, Waldstr\u00f8m M. Comparative analysis of HPV testing versus cytology in Danish cervical cancer screening: insights from a large-scale implementation study. Gynecol Oncol. 2024;191:45\u201355.","journal-title":"Gynecol Oncol"},{"key":"26382_CR11","doi-asserted-by":"crossref","unstructured":"Barto\u0161\u00edk M, Mor\u00e1\u0148ov\u00e1 L, Izadi N, Strmiskov\u00e1 J, Sebuyoya R, Holcakova J et al. Advanced technologies towards improved HPV diagnostics. J Med Virol. 2024;96.","DOI":"10.1002\/jmv.29409"},{"key":"26382_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2147\/RMHP.S296914","volume":"15","author":"K Okunade","year":"2022","unstructured":"Okunade K, Adejimi A, John-Olabode S, Oshodi Y, Oluwole A. An overview of HPV screening tests to improve access to cervical cancer screening amongst underserved populations: from development to implementation. Risk Manage Healthc Policy. 2022;15:1823\u201330.","journal-title":"Risk Manage Healthc Policy"},{"key":"26382_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ypmed.2018.07.012","volume":"114","author":"V Tsu","year":"2018","unstructured":"Tsu V, Njama-Meya D, Lim J, Murray M, De Sanjos\u00e9 S. Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa. Prev Med. 2018;114:205\u20138.","journal-title":"Prev Med"},{"key":"26382_CR14","doi-asserted-by":"crossref","unstructured":"Haque A, Kouriba B, A\u00efssatou Nd PA. Eliminating cervical cancer in Mali and Senegal, two Sub-Saharan countries: insights and optimizing solutions. Vaccines. 2020;8.","DOI":"10.3390\/vaccines8020181"},{"key":"26382_CR15","doi-asserted-by":"crossref","unstructured":"Gupta R, Singh S, Gupta S. Performance characteristics of the point-of-care tests for HPV-based cervical cancer screening: a systematic review and meta-analysis. J Public Health. 2024.","DOI":"10.1093\/pubmed\/fdae306"},{"key":"26382_CR16","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1128\/JCM.00529-16","volume":"54","author":"P Toliman","year":"2016","unstructured":"Toliman P, Badman S, Gabuzzi J, Silim S, Forereme L, Kumbia A, et al. Field evaluation of Xpert HPV Point-of-Care test for detection of human papillomavirus infection by use of Self-Collected vaginal and Clinician-Collected cervical specimens. J Clin Microbiol. 2016;54:1734\u20137.","journal-title":"J Clin Microbiol"},{"key":"26382_CR17","doi-asserted-by":"crossref","unstructured":"Effah K, Wormenor C, Tekpor E, Amuah J, Essel N, Gedzah I et al. Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: experience from Battor, Ghana. PLOS Global Public Health. 2023;3.","DOI":"10.1371\/journal.pgph.0001639"},{"key":"26382_CR18","doi-asserted-by":"crossref","unstructured":"Joseph J, Demke O, Ameyan L, Bitilinyu-Bango J, Bourgoin B, Diop M et al. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries. BMJ Open. 2023;13.","DOI":"10.1136\/bmjopen-2022-065074"},{"key":"26382_CR19","doi-asserted-by":"crossref","unstructured":"Grantz K, Girdwood S, Muriuki A, Carmona S, Nichols B, Khan S. Assessing feasibility and effectiveness of point-of-care limited HPV genotype tests in cervical cancer screening: a modelling study. 2025.","DOI":"10.1101\/2025.03.13.25323880"},{"key":"26382_CR20","doi-asserted-by":"crossref","unstructured":"Desta M, Getaneh T, Yeserah B, Worku Y, Eshete T, Birhanu MY et al. Cervical cancer screening utilization and predictors among eligible women in ethiopia: A systematic review and meta-analysis. PLoS ONE. 2021;16.","DOI":"10.1371\/journal.pone.0259339"},{"key":"26382_CR21","doi-asserted-by":"crossref","unstructured":"Mohammed E, Taye G, Assefa M, Aman H, Addissie A, Jemal A. Cervical cancer screening utilization and barriers to uptake in ethiopia: an umbrella review. Cancer Control: J Moffitt Cancer Cent. 2024;31.","DOI":"10.1177\/10732748241310575"},{"issue":"1","key":"26382_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1186\/s12885-024-13079-8","volume":"24","author":"EG Mekonen","year":"2024","unstructured":"Mekonen EG, Gebrehana DA, Tamir TT. Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys. BMC Cancer. 2024;24(1):1304.","journal-title":"BMC Cancer"},{"issue":"9","key":"26382_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1158\/1940-6207.CAPR-19-0156","volume":"12","author":"M Gizaw","year":"2019","unstructured":"Gizaw M, Teka B, Ruddies F, Abebe T, Kaufmann AM, Worku A, et al. Uptake of cervical cancer screening in Ethiopia by Self-Sampling HPV DNA compared to visual inspection with acetic acid: A cluster randomized trial. Cancer Prev Res (Phila). 2019;12(9):609\u201316.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"26382_CR24","first-page":"1","volume":"34","author":"A Derbie","year":"2023","unstructured":"Derbie A, Mekonnen D, Nibret E, Misgan E, Maier M, Woldeamanuel Y, et al. Cervical cancer in ethiopia: a review of the literature. Cancer Causes Control. 2023;34(1):1\u201311.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"26382_CR25","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1038\/s41598-025-96347-2","volume":"15","author":"BL Seifu","year":"2025","unstructured":"Seifu BL, Negussie YM, Asnake AA, Asebe HA, Fente BM, Asmare ZA, et al. Wealth-related inequalities of women\u2019s cervical cancer screening in 11 Sub-Saharan African countries: evidence from a pooled decomposition analysis. Sci Rep. 2025;15(1):12289.","journal-title":"Sci Rep"},{"issue":"56","key":"26382_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4103\/ijmr.ijmr_1143_23","volume":"158","author":"R Gupta","year":"2023","unstructured":"Gupta R, Gupta S. Point-of-care tests for human papillomavirus detection in uterine cervical samples: A review of advances in resource-constrained settings. Indian J Med Res. 2023;158(56):509\u201321.","journal-title":"Indian J Med Res"},{"issue":"1","key":"26382_CR27","doi-asserted-by":"publisher","first-page":"e065074","DOI":"10.1136\/bmjopen-2022-065074","volume":"13","author":"J Joseph","year":"2023","unstructured":"Joseph J, Demke O, Ameyan L, Bitilinyu-Bango J, Bourgoin B, Diop M, et al. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries. BMJ Open. 2023;13(1):e065074.","journal-title":"BMJ Open"},{"issue":"1","key":"26382_CR28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12885-023-11533-7","volume":"23","author":"K Tsegaye","year":"2023","unstructured":"Tsegaye K, Hagos A, Kindie H, Minyihun A, Teshale G. Evaluation of cervical cancer screening program in Gondar City administration public health facilities, Northwest Ethiopia, 2021: mixed method approach. BMC Cancer. 2023;23(1):1034.","journal-title":"BMC Cancer"},{"issue":"4","key":"26382_CR29","doi-asserted-by":"publisher","first-page":"e0321076","DOI":"10.1371\/journal.pone.0321076","volume":"20","author":"A Abate","year":"2025","unstructured":"Abate A, Munshea A, Nibret E, Bezabih B, Amare B, Yismaw G. Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara regional State, Ethiopia. PLoS ONE. 2025;20(4):e0321076.","journal-title":"PLoS ONE"},{"key":"26382_CR30","doi-asserted-by":"publisher","first-page":"107327482211149","DOI":"10.1177\/10732748221114980","volume":"29","author":"AL Bogale","year":"2022","unstructured":"Bogale AL, Teklehaymanot T, Kassie GM, Medhin G, Ali JH, Belay NB. Performance of visual inspection with acetic acid for cervical cancer screening as compared to human papillomavirus deoxyribonucleic acid testing among women with HIV in ethiopia: A comparative Cross-sectional study. Cancer Control. 2022;29:10732748221114980.","journal-title":"Cancer Control"},{"key":"26382_CR31","unstructured":"Organization WH. WHO prequalifies additional HPV test expanding options as countries pursue cervical cancer elimination. 2023."},{"key":"26382_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/13697137.2018.1439917","volume":"21","author":"P Toliman","year":"2018","unstructured":"Toliman P, Kaldor J, Tabrizi S, Vallely A. Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric. 2018;21:235\u20138.","journal-title":"Climacteric"},{"key":"26382_CR33","doi-asserted-by":"crossref","unstructured":"Mhango P, Kumitawa A, Malata M, Tang J, Chipeta E, Kandeya B et al. Acceptability, feasibility and appropriateness of integrating HPV self-sampling for cervical cancer screening into voluntary family planning services in Malawi. BMC Public Health. 2025;25.","DOI":"10.1186\/s12889-025-23822-w"},{"issue":"1","key":"26382_CR34","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1093\/pubmed\/fdae306","volume":"47","author":"R Gupta","year":"2025","unstructured":"Gupta R, Singh S, Gupta S. Performance characteristics of the point-of-care tests for HPV-based cervical cancer screening: a systematic review and meta-analysis. J Public Health (Oxf). 2025;47(1):e106\u201315.","journal-title":"J Public Health (Oxf)"},{"key":"26382_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pvr.2016.02.004","volume":"2","author":"Z Mbulawa","year":"2016","unstructured":"Mbulawa Z, Wilkin T, Goeieman B, Swarts A, Williams S, Levin S, et al. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women. Papillomavirus Res. 2016;2:56\u201360.","journal-title":"Papillomavirus Res"},{"key":"26382_CR36","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1128\/JCM.00897-16","volume":"54","author":"K Cuschieri","year":"2016","unstructured":"Cuschieri K, Geraets D, Cuzick J, Cadman L, Moore C, Vanden Broeck D, et al. Performance of a Cartridge-Based assay for detection of clinically significant human papillomavirus (HPV) infection: lessons from VALGENT (Validation of HPV genotyping Tests). J Clin Microbiol. 2016;54:2337\u201342.","journal-title":"J Clin Microbiol"},{"key":"26382_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41416-023-02490-w","volume":"130","author":"L Downham","year":"2023","unstructured":"Downham L, Jaafar I, Rol M-L, Nyaga VN, Valls J, Baena A, et al. Accuracy of HPV E6\/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis. Br J Cancer. 2023;130:517\u201325.","journal-title":"Br J Cancer"},{"key":"26382_CR38","doi-asserted-by":"crossref","unstructured":"Yu L-L, Jiang M, Qu P, Wu Z, Sun P, Xi M et al. Clinical evaluation of human papillomavirus 16\/18 oncoprotein test for cervical cancer screening and HPV positive women triage. Int J Cancer. 2018;143.","DOI":"10.1002\/ijc.31368"},{"key":"26382_CR39","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1128\/JCM.03432-13","volume":"52","author":"L-N Kang","year":"2014","unstructured":"Kang L-N, Jeronimo J, Qiao Y, Zhao F, Chen W, Valdez M, et al. Optimal positive cutoff points for CareHPV testing of Clinician- and Self-Collected specimens in primary cervical cancer screening: an analysis from rural China. J Clin Microbiol. 2014;52:1954\u201361.","journal-title":"J Clin Microbiol"},{"key":"26382_CR40","doi-asserted-by":"crossref","unstructured":"Kelly H, Mayaud P, Segondy M, Pai NP, Peeling R. A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening. Sex Transm Infect. 2017;93.","DOI":"10.1136\/sextrans-2016-053070"},{"key":"26382_CR41","doi-asserted-by":"crossref","unstructured":"Mungo C, Guliam A, Chinula L, Inturrisi F, Msowoya L, Mkochi T et al. Comparison of the screenfire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi. Infect Agents Cancer. 2024;19.","DOI":"10.1186\/s13027-024-00585-4"},{"key":"26382_CR42","doi-asserted-by":"crossref","unstructured":"Moyo S, Ramogola-Masire D, Moraka N, Tawe L, Noubary F, Motsumi K et al. Comparison of the AmpFire\u00ae Multiplex HPV Assay to the Xpert\u00ae HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation. Res Square. 2023.","DOI":"10.21203\/rs.3.rs-2606441\/v1"},{"key":"26382_CR43","unstructured":"Organization WH. New recommendations for screening and treatment to prevent cervical cancer. 2021. 2023."},{"key":"26382_CR44","doi-asserted-by":"crossref","unstructured":"Li H, Tan H, Lv X, Han Z, Wang Y, Gao S et al. Field-Applicable Loop-Mediated isothermal amplification for the detection of seven common human papillomavirus subtypes. Trop Med Infect Disease. 2024;9.","DOI":"10.3390\/tropicalmed9100240"},{"key":"26382_CR45","doi-asserted-by":"crossref","unstructured":"Lamsisi M, Benlghazi A, Kouach J, Laraqui A, Ennaji M, Chauleur C et al. Isothermal nucleic acid amplification for Point-of-Care primary cervical cancer screening. Viruses. 2024;16.","DOI":"10.3390\/v16121852"},{"key":"26382_CR46","doi-asserted-by":"crossref","unstructured":"Barra M, Wilkinson A, Goli EA, Atif K, Osman H. N, One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique. Nat Commun. 2025;16.","DOI":"10.1038\/s41467-025-62454-x"},{"issue":"1","key":"26382_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13643-023-02252-y","volume":"12","author":"SF Mekuria","year":"2023","unstructured":"Mekuria SF, Timmermans S, Borgfeldt C, Jerkeman M, Johansson P, Linde DS. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis. Syst Rev. 2023;12(1):103.","journal-title":"Syst Rev"},{"issue":"1","key":"26382_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12905-020-01158-4","volume":"21","author":"A Kamath Mulki","year":"2021","unstructured":"Kamath Mulki A, Withers M. Human papilloma virus self-sampling performance in low- and middle-income countries. BMC Womens Health. 2021;21(1):12.","journal-title":"BMC Womens Health"},{"key":"26382_CR49","doi-asserted-by":"crossref","unstructured":"Sechi I, Muresu N, Puci M, Saderi L, Del Rio A, Cossu A et al. Preliminary results of feasibility and acceptability of Self-Collection for cervical screening in Italian women. Pathogens. 2023;12.","DOI":"10.3390\/pathogens12091169"},{"key":"26382_CR50","doi-asserted-by":"crossref","unstructured":"Duan R, Yang H, Zhai X, Yu J, Lu C, Yang W et al. Accuracy and acceptability of self-sampling HPV testing in cervical cancer screening: a population-based study in rural Yunnan, China. Sci Rep. 2025;15.","DOI":"10.1038\/s41598-025-09292-5"},{"key":"26382_CR51","doi-asserted-by":"crossref","unstructured":"Seely S, Zingg J, Joshi P, Slomovitz B, Schlumbrecht M, Kobetz E et al. Point-of-Care molecular test for the detection of 14 High-Risk genotypes of human papillomavirus in a single tube. Anal Chem. 2023.","DOI":"10.1021\/acs.analchem.3c01723"},{"key":"26382_CR52","doi-asserted-by":"crossref","unstructured":"Mwenda V, Bor J-P, Nyangasi M, Njeru J, Olwande S, Njiri P et al. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: findings and lessons from a Kenyan pilot study (2019\u20132020). PLoS ONE. 2023;18.","DOI":"10.1371\/journal.pone.0286202"},{"key":"26382_CR53","unstructured":"Arbyn M, Simon M, Peeters E, Xu L, Meijer C, Berkhof J et al. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. clinical microbiology and infection: the official publication of the European society of clinical microbiology and infectious diseases. 2021."},{"key":"26382_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14737159.2021.1873769","volume":"21","author":"T Moehling","year":"2021","unstructured":"Moehling T, Choi G, Dugan L, Salit M, Meagher R. LAMP diagnostics at the Point-of-Care: emerging trends and perspectives for the developer community. Expert Rev Mol Diagn. 2021;21:43\u201361.","journal-title":"Expert Rev Mol Diagn"},{"key":"26382_CR55","first-page":"53","volume":"51","author":"E Nikolova","year":"2024","unstructured":"Nikolova E. Application of lamp as a Point-of-Care diagnostic assay in remote and Low-Income regions: Mini-Review. Acta Med Bulg. 2024;51:53\u20137.","journal-title":"Acta Med Bulg"},{"key":"26382_CR56","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1039\/C9AY02383F","volume":"12","author":"M Anton","year":"2020","unstructured":"Anton M, Mor\u00e1\u0148ov\u00e1 L, Hrstka R, Barto\u0161\u00edk M. Application of an electrochemical LAMP-based assay for screening of HPV16\/HPV18 infection in cervical samples. Anal Methods. 2020;12:822\u20139.","journal-title":"Anal Methods"},{"key":"26382_CR57","doi-asserted-by":"publisher","first-page":"18083","DOI":"10.1021\/acs.analchem.2c04701","volume":"94 51","author":"J Wang","year":"2022","unstructured":"Wang J, Jing G, Huang W, Xin L, Du J, Cai X, et al. Rapid in situ hydrogel LAMP for On-Site Large-Scale parallel Single-Cell HPV detection. Anal Chem. 2022;94 51:18083\u201391.","journal-title":"Anal Chem"},{"key":"26382_CR58","doi-asserted-by":"crossref","unstructured":"Serra-Casas E, Manrique P, Ding X, Carrasco-Escobar G, Alava F, Gave A et al. Loop-mediated isothermal DNA amplification for asymptomatic malaria detection in challenging field settings: technical performance and pilot implementation in the Peruvian Amazon. PLoS ONE. 2017;12.","DOI":"10.1371\/journal.pone.0185742"},{"key":"26382_CR59","first-page":"417","volume":"31","author":"J Dykens","year":"2020","unstructured":"Dykens J, Smith J, Demment M, Marshall E, Schuh T, Peters K, et al. Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review. Cancer Causes Control. 2020;31:417\u201329.","journal-title":"Cancer Causes Control"},{"key":"26382_CR60","doi-asserted-by":"crossref","unstructured":"Madsen KG, Mosgaard JS, Oshosen M, Swai P, Mwaiselage J, Rasch V et al. Barriers and facilitators for implementation of HPV-based cervical cancer screening in tanzania: a qualitative study among healthcare providers, stakeholders, and Tanzanian women. Global Health Action. 2025;18.","DOI":"10.1080\/16549716.2025.2491852"},{"key":"26382_CR61","doi-asserted-by":"crossref","unstructured":"Rahman R, Clark M, Collins Z, Traor\u00e9 F, Dioukhane E, Thiam H et al. Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review. Global Health Action. 2019;12.","DOI":"10.1080\/16549716.2019.1587894"},{"key":"26382_CR62","doi-asserted-by":"publisher","first-page":"948471","DOI":"10.3389\/fonc.2022.948471","volume":"12","author":"CB Dartibale","year":"2022","unstructured":"Dartibale CB, Prado GC, Carobeli LR, Meirelles LEF, Damke G, Damke E, et al. Recent HPV self-sampling use for cervical cancer screening in Latin America and caribbean: a systematic review. Front Oncol. 2022;12:948471.","journal-title":"Front Oncol"},{"issue":"9","key":"26382_CR63","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/diagnostics15091176","volume":"15","author":"M Gomes","year":"2025","unstructured":"Gomes M, Provaggi E, Pembe AB, Olaitan A, Gentry-Maharaj A. Advancing cervical cancer prevention equity: innovations in Self-Sampling and digital health technologies across healthcare settings. Diagnostics. 2025;15(9):1176.","journal-title":"Diagnostics"},{"key":"26382_CR64","doi-asserted-by":"crossref","unstructured":"Gomes M, Provaggi E, Pembe A, Olaitan A, Gentry-Maharaj A. Improving Accessibility of Cervical Cancer Screening: A Global Perspective on Self-Sampling and Digital Innovation. 2024.","DOI":"10.20944\/preprints202412.1888.v1"},{"key":"26382_CR65","unstructured":"Erwin E. Randomized trial for a mobile health approach to increase uptake of cervical cancer screening in Tanzania. 2016."},{"key":"26382_CR66","doi-asserted-by":"publisher","first-page":"1430968","DOI":"10.3389\/fpubh.2024.1430968","volume":"12","author":"MM Fullerton","year":"2024","unstructured":"Fullerton MM, Ford C, D\u2019Silva C, Chiang B, Onobrakpor S-I, Dievert H, et al. HPV self-sampling implementation strategies to engage under screened communities in cervical cancer screening: a scoping review to inform screening programs. Front Public Health. 2024;12:1430968.","journal-title":"Front Public Health"},{"key":"26382_CR67","unstructured":"Organization WH. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV). 2021."},{"key":"26382_CR68","doi-asserted-by":"publisher","first-page":"1006038","DOI":"10.3389\/fmed.2022.1006038","volume":"9","author":"ML Rol","year":"2022","unstructured":"Rol ML, Picconi MA, Ferrera A, S\u00e1nchez GI, Hern\u00e1ndez ML, Lineros J, et al. Implementing HPV testing in 9 Latin American countries: the laboratory perspective as observed in the ESTAMPA study. Front Med (Lausanne). 2022;9:1006038.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"26382_CR69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12916-021-02026-0","volume":"19","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Bao H, Ma L, Song B, Di J, Wang L, et al. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in china: a nationwide, population-based study. BMC Med. 2021;19(1):164.","journal-title":"BMC Med"},{"issue":"1","key":"26382_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ijc.31633","volume":"144","author":"R Rezhake","year":"2019","unstructured":"Rezhake R, Hu SY, Zhao S, Xu XQ, Zhao XL, Zhang L, et al. Eight-type human papillomavirus E6\/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV\u2010positive women. Int J Cancer. 2019;144(1):34\u201342.","journal-title":"Int J Cancer"},{"key":"26382_CR71","unstructured":"S\u00e1nchez V\u00e1squez G, Downham L, Forestier M, Romero P, Mendoza L, Mongel\u00f3s P et al. Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs. 2024."},{"key":"26382_CR72","unstructured":"Path. Cervical cancer screening and treatment in low-resource settings: practical experience from PATH. 2013."},{"key":"26382_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13027-020-00328-1","volume":"15","author":"W Zhang","year":"2020","unstructured":"Zhang W, Du H, Huang X, Wang C, Duan X, Liu Y, et al. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening. Infect Agent Cancer. 2020;15:65.","journal-title":"Infect Agent Cancer"},{"issue":"7","key":"26382_CR74","doi-asserted-by":"publisher","first-page":"e0181156","DOI":"10.1371\/journal.pone.0181156","volume":"12","author":"L Sigfrid","year":"2017","unstructured":"Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: A systematic review. PLoS ONE. 2017;12(7):e0181156.","journal-title":"PLoS ONE"},{"issue":"11","key":"26382_CR75","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1097\/QAD.0000000000003972","volume":"38","author":"E Gram","year":"2024","unstructured":"Gram E, Moseholm E, N\u00f8rl\u00f8v AB, Wilken-Jensen C, Thorsteinsson K, Pedersen BT, et al. Cervical cancer screening integrated in routine clinical care of women with HIV. Aids. 2024;38(11):1648\u201357.","journal-title":"Aids"},{"key":"26382_CR76","doi-asserted-by":"crossref","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363.","DOI":"10.1136\/bmj.k4823"},{"issue":"9","key":"26382_CR77","doi-asserted-by":"publisher","first-page":"e1336","DOI":"10.1016\/S2214-109X(22)00271-6","volume":"10","author":"AJ Vallely","year":"2022","unstructured":"Vallely AJ, Saville M, Badman SG, Gabuzzi J, Bolnga J, Mola GD, et al. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua new guinea: a prospective, single-arm intervention trial (HPV-STAT). Lancet Global Health. 2022;10(9):e1336\u201346.","journal-title":"Lancet Global Health"},{"issue":"1","key":"26382_CR78","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s43058-021-00243-5","volume":"2","author":"U Nwaozuru","year":"2021","unstructured":"Nwaozuru U, Obiezu-Umeh C, Obi-Jeff C, Shato T, Gbaja-Biamila T, Oladele D, et al. A systematic review of randomized control trials of HPV self-collection studies among women in sub-Saharan Africa using the RE-AIM framework. Implement Sci Commun. 2021;2(1):138.","journal-title":"Implement Sci Commun"},{"issue":"1","key":"26382_CR79","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13643-022-02017-z","volume":"11","author":"T Sefuthi","year":"2022","unstructured":"Sefuthi T, Nkonki L. A systematic review of economic evaluations of cervical cancer screening methods. Syst Rev. 2022;11(1):162.","journal-title":"Syst Rev"},{"issue":"9","key":"26382_CR80","doi-asserted-by":"publisher","first-page":"e0328803","DOI":"10.1371\/journal.pone.0328803","volume":"20","author":"A Wynn","year":"2025","unstructured":"Wynn A, Harris D, Modest A, Reyes MF, Wamakima B, Gaborone K, et al. Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: evidence from Botswana. PLoS ONE. 2025;20(9):e0328803.","journal-title":"PLoS ONE"},{"issue":"1","key":"26382_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ijc.29353","volume":"137","author":"J Bigoni","year":"2015","unstructured":"Bigoni J, Gundar M, Tebeu PM, Bongoe A, Sch\u00e4fer S, Fokom-Domgue J, et al. Cervical cancer screening in sub-Saharan africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. Int J Cancer. 2015;137(1):127\u201334.","journal-title":"Int J Cancer"},{"issue":"17","key":"26382_CR82","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1002\/cam4.4152","volume":"10","author":"R Duan","year":"2021","unstructured":"Duan R, Zhao X, Zhang H, Xu X, Huang L, Wu A, et al. Performance of cervical cancer screening and triage strategies among women living with HIV in China. Cancer Med. 2021;10(17):6078\u201388.","journal-title":"Cancer Med"},{"issue":"3","key":"26382_CR83","doi-asserted-by":"publisher","first-page":"e1003528","DOI":"10.1371\/journal.pmed.1003528","volume":"18","author":"HA Kelly","year":"2021","unstructured":"Kelly HA, Chikandiwa A, Sawadogo B, Gilham C, Michelow P, Lompo OG, et al. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South africa: A cohort study. PLoS Med. 2021;18(3):e1003528.","journal-title":"PLoS Med"},{"issue":"12","key":"26382_CR84","doi-asserted-by":"publisher","first-page":"e0296015","DOI":"10.1371\/journal.pone.0296015","volume":"18","author":"MA Razzak","year":"2023","unstructured":"Razzak MA, Islam MN, Aadeeb MS, Tasnim T. Digital health interventions for cervical cancer care: A systematic review and future research opportunities. PLoS ONE. 2023;18(12):e0296015.","journal-title":"PLoS ONE"},{"issue":"1","key":"26382_CR85","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s13063-020-04790-5","volume":"21","author":"JR Montealegre","year":"2020","unstructured":"Montealegre JR, Anderson ML, Hilsenbeck SG, Chiao EY, Cantor SB, Parker SL, et al. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial. Trials. 2020;21(1):872.","journal-title":"Trials"},{"issue":"1","key":"26382_CR86","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13063-025-09262-2","volume":"26","author":"M Asare","year":"2025","unstructured":"Asare M, Obiri-Yeboah D, Ken-Amoah S, Akakpo PK, Enyan NIE, Asmah E, et al. HPV self-sampling for cervical cancer screening among women living with HIV in ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial. Trials. 2025;26(1):550.","journal-title":"Trials"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26382-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:08:01Z","timestamp":1781629681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26382-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26382"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26382-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study used only published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"990"}}